This application note explores how an advanced 5 L single-use bioreactor enhances productivity, reduces costs and enables ...
The perfusion bioreactors market is booming due to rising biopharmaceutical demand, innovations in bioreactor design, and regulatory support. Key opportunities include smaller-scale systems for R&D ...
The university plays a vital role in addressing social challenges and improving quality of life. Its success is built on five dynamic institutes specializing in chemistry and biotechnology, food and ...
This infographic highlights how bench-scale single-use bioreactors help overcome these barriers with efficiency, flexibility ...
The biopharmaceutical and biotech industries face mounting challenges in regulated environments, including rising drug development costs, strict regulatory demands, and the need for scalable, ...
The global Single-use Bioprocessing Market, valued at US$16.51 billion in 2024, stood at US$18.01 billion in 2025 and is projected to ...
A pharmaceutical company’s automation upgrade shows how simulations can be used to test equipment limits, standardize systems ...
VintaBio announced it has filed provisional patents with the U.S. Patent and Trademark Office for a new approach to manufacturing biotherapeutics using adherent culturing methods in small-scale ...
WuXi Biologics completed the first commercial project Process Performance Qualification (PPQ) campaign for its three sets of 5,000 L single-use bioreactors (SUBs) in the second drug substance line of ...
Recent advances in cell culture technology have transformed the landscape of viral vaccine production, offering enhanced scalability, efficiency and adaptability compared to traditional egg‐based or ...
SAN DIEGO, CALIFORNIA / ACCESS Newswire / May 27, 2025 / Bora Biologics, a leading contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, announced a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results